Transient no reflow following primary percutaneous coronary intervention

Heart and Vessels

Volumn 29, Issue 4, 2014, Pages 429-436

  Jinnouchi, Hiroyuki ^a   Sakakura, Kenichi ^a   Wada, Hiroshi ^a   Arao, Kenshiro ^a   Kubo, Norifumi ^a   Sugawara, Yoshitaka ^a   Funayama, Hiroshi ^a   Momomura, Shin Ichi ^a   Ako, Junya ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Myocardial infarction; Percutaneous coronary intervention; Persistent no reflow; Transient no reflow

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HUMAN; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NO REFLOW PHENOMENON; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SYNDROME DELINEATION; TREATMENT RESPONSE; TREND STUDY; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BLOOD FLOW; KIDNEY; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; KIDNEY; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904091746     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-013-0379-1     Document Type: Article

References (27)

1. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13-20 (Pubitemid 36050955)
2. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, DeWood MA, Ribichini F (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 278:2093-2098 (Pubitemid 28016233)
3. Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM, Sonmez K, Mutlu B, Ozdemir N, Erentug V (2008) Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J 72:716-721 (Pubitemid 351716675)
4. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, Matsui H, Toki Y, Ito T, Hayakawa T (2000) Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36:1202-1209
5. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schomig A, Kastrati A (2010) 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:2383-2389
6. Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R (2003) No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 145:42-46 (Pubitemid 36034496)
7. Chen Y, Wang C, Yang X, Wang L, Sun Z, Liu H, Chen L (2012) Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart Vessels 27:243-249
8. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K (2003) Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41:1-7 (Pubitemid 36044395)
9. Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, Ikushima M, Tanaka K, Kitakaze M, Hori M, Higashino Y, Fujii K (2001) Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 38:472-477 (Pubitemid 32721776)
10. Barcin C, Denktas AE, Lennon RJ, Hammes L, Higano ST, Holmes DR Jr, Garratt KN, Lerman A (2004) Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv 61:484-491 (Pubitemid 38419135)
11. Kobatake R, Sato T, Fujiwara Y, Sunami H, Yoshioka R, Ikeda T, Saito H, Ujihira T (2011) Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels 26:379-384
12. Butler MJ, Chan W, Taylor AJ, Dart AM, Duffy SJ (2011) Management of the no-reflow phenomenon. Pharmacol Ther 132:72-85
13. Chan W, Stub D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan AL, New G, Black A, Shaw JA, Reid CM, Dart AM, Duffy SJ (2012) Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol 109:478-485
14. Klein LW, Kern MJ, Berger P, Sanborn T, Block P, Babb J, Tommaso C, Hodgson JM, Feldman T (2003) Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory. Catheter Cardiovasc Interv 60:194-201 (Pubitemid 37203996)
15. Lee CH, Wong HB, Tan HC, Zhang JJ, Teo SG, Ong HY, Low A, Sutandar A, Lim YT (2005) Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry. J Interv Cardiol 18:261-266 (Pubitemid 41725551)
16. Mehta RH, Harjai KJ, Boura J, Cox D, Stone GW, O'Neill W, Grines CL (2003) Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol 92:1445-1447 (Pubitemid 37532569)
17. Aguirre FV, Younis LT, Chaitman BR, Ross AM, McMahon RP, Kern MJ, Berger PB, Sopko G, Rogers WJ, Shaw L, Knnaterud G, Braunwald E (1995) Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. Circulation 91:2541-2548
18. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, Wu CJ (2002) Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest 122:1322-1332
19. Ambrose JA, Almeida OD, Sharma SK, Dangas G, Ratner DE (1997) Angiographic evolution of intracoronary thrombus and dissection following percutaneous transluminal coronary angioplasty (the Thrombolysis and Angioplasty in Unstable Angina [TAUSA] trial). Am J Cardiol 79:559-563 (Pubitemid 27143154)
20. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E (2001) Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103:2550-2554 (Pubitemid 32521963)
21. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM (1990) Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 82:1193-1202
22. Sakakura K, Ako J, Wada H, Kubo N, Momomura S (2012) ACC/AHA classification of coronary lesions reflects medical resource use in current percutaneous coronary interventions. Catheter Cardiovasc Interv 80:370-376
23. Mori M, Sakakura K, Wada H, Ikeda N, Jinnouchi H, Sugawara Y, Kubo N, Momomura SI, Ako J (2012) Left ventricular apical aneurysm following primary percutaneous coronary intervention. Heart Vessels. doi:10.1007/s00380-012-0301-2
24. Koc F, Kalay N, Kilci H, Ceyhan K, Celik A, Kadi H, Calapkorur B, Onalan O (2011) The relationship between renal functions and thrombolysis in myocardial infarction frame count in patients with slow coronary flow. Kaohsiung J Med Sci 27:55-58
25. Yilmaz MB, Yalta K (2009) Coronary flow slows as renal function worsens. Clin Cardiol 32:278-282
26. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813-818 (Pubitemid 41175724)
27. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, Michalis LK, Serruys PW (2007) Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 50:573-583 (Pubitemid 47198999)